We reported a case of a former water polo player who suffered from a non-traumatic right subclavian vein thrombosis. An otherwise healthy former athlete developed thrombosis of the right subclavian vein. He presented with swelling of his right arm. Diagnosis was made by colour doppler ultrasonography. He received low molecular weight heparin as initial treatment followed by thrombolytic therapy with alteplase and heparin infusion. He continued with outpatient anticoagulant therapy for six months before returning to usual daily activities. There is no evidence or report on the time length after ending of an athletic pursuit that would predispose to the formation of subclavian vein thrombosis. Early diagnosis and treatment of patients with subclavian vein thrombosis is important in order to avoid complications, occupational disability and the adverse impact on the patient's quality of life. (Hong Kong j.emerg.med. 2017;24:35-36) 
Introduction
Upper extremity deep vein thrombosis refers to thrombosis of the axillary and/or subclavian veins; and with a reported incidence rate of approximately 2/100000 persons per year. 1 Subclavian vein thrombosis is most commonly associated with anatomic abnormalities, intravenous catheters and trauma. 2 It can also occur in young, otherwise healthy people who participate in repetitive upper extremity activities, known as effort thrombosis. 3 Herein, we reported an unusual case of a former water polo player who suffered a non-traumatic right subclavian vein thrombosis.
Case report
A 46-year-old former water polo player, previously healthy, presented to the emergency department with non-pitting oedema of his right dominant arm which started five days earlier but subsided completely, then re-occurred on the day of admission. He complained of pain and tightness in his right arm. There was sixcentimetres difference in circumference compared to the contralateral side, peripheral arterial pulses were palpable and symmetrical, superficial veins were prominent. History and the rest of the physical exam were unremarkable. The patient denied any drug or illegal substance abuse, physical activity, trauma or infection. Initial laboratory findings were unremarkable except for an elevated D-dimer values. Plain chest film showed no anatomic abnormalities of the thoracic outlet. Colour doppler ultrasonography confirmed that the right subclavian vein was dilated and filled with hyperechoic thrombus. Double axillary vein, brachial vein, veins of the forearm, both jugular and left subclavian vein and all arteries in the right arm were patent with no sign of thrombosis. Diagnosis was made of subacute right subclavian vein thrombosis and the patient was admitted to the intensive care unit, started on low molecular weight heparin. Since there was no contraindication for thrombolytic therapy, an infusion of tissue plasminogen activator (alteplase) and heparin was initiated. The next day on a follow-up ultrasonography there was a significant change and increase in blood flow. Other coagulation tests were performed to exclude coagulopathy, which were unremarkable. Oral anticoagulant therapy was started and heparin was substituted by low molecular weight heparin. The patient was discharged from hospital with an elastic compression sleeve and he continued to take oral anticoagulant for 6 months before he returned to normal everyday activities.
Discussion
Our patient had no proven coagulopathy, suffered no dehydration, had no immobilisation, trauma or invasive procedure performed on that arm. Water polo players, who use their arm in the overhead position, are predisposed to subclavian vein thrombosis. Due to stasis of blood and tears of the intima of the vein resulting from stretching and mechanical compression of the blood vessel when the subclavian vein passes through the narrowed thoracic outlet. His former water polo career, which ended ten years earlier, made him susceptible for effort-induced thrombosis. Since initial oedema resolved with rest, it could point to musculoskeletal aetiology resulting in a delay to seek medical help. Late diagnosis and treatment could contribute to higher incidence of complications, most commonly pulmonary embolism and superior vena cava syndrome. 4 Primary therapy for young, otherwise healthy patients is anticoagulation and thrombolytic therapy. Safe and effective alternative for outpatient treatment included initial low molecular weight heparin, followed by warfarin therapy, continued 3 to 6 months after discharge. Using thrombolysis to restore patency of vessel in this case could have minimised impairment to endothelium of vessels and long term morbidity. 1 In recurrent and refractory cases, balloon dilatation with or without stenting of the subclavian vein or surgical thrombectomy and resection of the first rib or clavicle would be indicated. It is important to achieve an early diagnose and treat patients with subclavian vein thrombosis because this syndrome could lead to occupational disability and adversely impact the patient's quality of life. 4 There is no scientific data to inform on the time length after ending of athletic pursuit that could predispose to the formation of subclavian vein thrombosis.
